International Journal of Health Policy and Management

1. Evidence-Informed Deliberative Processes for Legitimate Health Benefit Package Design − Part I: Conceptual Framework

Articles in Press, Corrected Proof, Available Online from 10 November 2021

10.34172/ijhpm.2021.158

Rob Baltussen; Maarten Jansen; Wija oortwijn

2. Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide

Articles in Press, Corrected Proof, Available Online from 10 November 2021

10.34172/ijhpm.2021.159

Wija Oortwijn; Maarten Jansen; Rob Baltussen

3. The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs

Volume 11, Issue 5, May 2022, Pages 642-650

10.34172/ijhpm.2020.198

Rick A. Vreman; Lourens T. Bloem; Stijn van Oirschot; Jarno Hoekman; Menno E. van der Elst; Hubert GM Leufkens; Olaf H. Klungel; Wim G. Goettsch; Aukje K. Mantel-Teeuwisse

4. Ethical and Social Values for Paediatric Health Technology Assessment and Drug Policy

Volume 11, Issue 3, March 2022, Pages 374-382

10.34172/ijhpm.2020.144

Avram E. Denburg; Mita Giacomini; Wendy Ungar; Julia Abelson

5. Experiences of Using Cochrane Systematic Reviews by Local HTA Units

Volume 11, Issue 2, February 2022, Pages 112-117

10.34172/ijhpm.2020.133

Thomas G. Poder; Marc Rhainds; Christian A. Bellemare; Simon Deblois; Imane Hammana; Catherine Safianyk; Sylvie St-Jacques; Pierre Dagenais

6. A Process for Evaluating Quality Decision-Making Practices During the Development, Review and Reimbursement of Medicines

Volume 11, Issue 2, February 2022, Pages 128-137

10.34172/ijhpm.2020.86

Magdalena Bujar; Neil McAuslane; Stuart Walker; Sam Salek

7. Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement; Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”

Volume 10, Issue 4, April 2021, Pages 228-231

10.34172/ijhpm.2020.46

Mireille Goetghebeur; Marjo Cellier

8. Evidence-Informed Deliberative Processes for HTA Around the Globe: Exploring the Next Frontiers of HTA and Best Practices; Comment on “Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe”

Volume 10, Issue 4, April 2021, Pages 232-236

10.34172/ijhpm.2020.145

Unni Gopinathan; Trygve Ottersen; Pascale-Renée Cyr; Kalipso Chalkidou

9. The Potential for Early Health Economic Modelling in Health Technology Assessment and Reimbursement Decision-Making; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Volume 10, Issue 2, February 2021, Pages 98-101

10.15171/ijhpm.2020.17

Hansoo Kim; Stephen Goodall; Danny Liew

10. Expanding the Role of Early Health Economic Modelling in Evaluation of Health Technologies; Comment on “Problems and Promises of Health Technologies: The Role of Early Health Economic Modeling”

Volume 10, Issue 2, February 2021, Pages 102-105

10.15171/ijhpm.2020.18

Carlo Federici; Aleksandra Torbica

11. Exploratory, Participatory and Iterative Assessment of Value: A Response to Recent Commentaries

Volume 10, Issue 1, January 2021, Pages 42-44

10.34172/ijhpm.2020.76

Janneke P.C. Grutters; Tim M. Govers; Jorte Nijboer; Marcia Tummers; Gert Jan van der Wilt; Maroeska M. Rovers

12. Comparing 3 Approaches for Making Vaccine Adoption Decisions in Thailand

Volume 9, Issue 10, October 2020, Pages 439-447

10.15171/ijhpm.2020.01

Waranya Rattanavipapong; Ritika Kapoor; Yot Teerawattananon; Jos Luttjeboer; Siobhan Botwright; Rachel A. Archer; Birgitte Giersing; Raymond C. W. Hutubessy